In undertaking this survey, researchers aimed to assess the limitations of ctDNA testing in the clinic, as well as areas in which it is considered clinically meaningful.
An experimental patch could bring the medical world one step closer to rapid at-home melanoma testing, eliminating the need for a biopsy or blood draw. The ExoPatch successfully distinguished melanoma ...
FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced a poster presentation on ...
Melanoma testing could one day be done at home with a skin patch and test strip with two lines, similar to COVID-19 home tests, according to University of Michigan researchers. Developed with funding ...
New data from the MEL-SELF trial show gaps in melanoma self-surveillance confidence, highlighting opportunities to improve ...
Discusses Clinical Utility and Evidence Supporting DecisionDx Melanoma Test and DECIDE Study March 23, 2026 4:30 ...
Melanoma is a deadly form of skin cancer that is typically removed surgically. Now, researchers publishing in ACS Nano report ...
A new personalized skin cancer treatment is showing success in preventing the return of high-risk melanoma. Five-year study results were announced on Tuesday by pharmaceutical companies Moderna Inc ...
Nine of the 10 most common cancer deaths in Australia are caused by solid tumors, but in most cases it's the cancer's spread to other parts of the body—known as metastasis—that proves fatal. Subscribe ...
Immunotherapy uses the power of your immune system to fight your cancer. One type of immunotherapy is called an immune checkpoint inhibitor. Your immune system has built-in checkpoints that keep it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results